Efficacy and Safety of Esmolol in Neonatal Cardiac Surgery with Cardiopulmonary Bypass (CPB) for d-Transposition of the Great Arteries (d-TGA)
No relevant hemodynamic difference was seen between neonates treated with perioperative esmolol and the control group and outcome did not differ. This indicates non-inferiority of perioperative betablocker therapy in young age. Prospective and placebo-controlled assessment of perioperative esmolol therapy in neonates is needed.
Authors
- David Backhoff (ORCID: https://orcid.org/0000-0001-7478-5005)
- Hakan Akintürk (ORCID: https://orcid.org/0000-0002-9276-7350)
- Thomas Zajonz (ORCID: https://orcid.org/0000-0002-1693-8461)
- Christian Jux (ORCID: https://orcid.org/0000-0003-2143-5153)
- Inga Gruschwitz
- Christoph Neuhäuser
- Anna-Eva Blank
Institutions
- Justus-Liebig-Universität Gießen (DE)
Publication Details
- Journal
- Pediatric Cardiology
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1007/s00246-024-03671-x
- Primary Topic
- Congenital Heart Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00